RxDoctor Payments Data

Nikolaos Botsoglou

Hematology · Cheektowaga, NYNPI 1225015621

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.1% of the total across 421 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,413 and has fallen 95.5% since, to $107 in 2025.

$10,375in general payments, 2019–2025

Across 421 payments — averaging $24.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • UCB, Inc.$734
  • AstraZeneca$696
  • GSK$638
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$5255%
  • Food & beverage$9,76594%
  • Education$851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,375 in reported general payments places this provider in the 75th percentile of 157 hematology providers in New York.

See all hematology providers in New York →

Other hematology in Cheektowaga

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →